Sort
23,748 grants matching “melanoma”
Modulating the localization and persistence of microbial neoantigen vaccine vectors to enhance therapeutic efficacy
$638,120Nicholas Arpaia · Columbia University Health Sciences · R01 · FY2025 · CA
Reducing Skin Cancer Risk in Childhood Cancer Survivors
$638,094Alan C Geller · Harvard School Of Public Health · R01 · FY2016 · CA
Utilizing nucleic acid scavengers to elucidate how DNA/RNA-containing DAMPs promote pancreatic cancer metastasis and to mitigate such processes
$638,056Bruce Alan Sullenger · Duke University · R01 · FY2025 · CA
(PQ5) Mitochondrial Heterogeneity in Melanoma Tumor and Immune Responses
$638,007Gerald S Shadel · Salk Institute For Biological Studies · R01 · FY2022 · CA
Project 3: Tools for Capturing Immune Cell/Cancer Cell Interactions in Cancer Immunotherapies and Combination Immunotherapies
$637,991James R. Heath · California Institute Of Technology · U54 · FY2015 · CA
Roles of NADPH Oxidase 5 and Dual Oxidase 2 in Cancer
$637,940James Doroshow · Division Of Basic Sciences - Nci · ZIA · FY2015 · CA
Genetic Epidemiology of Melanoma
$637,867David E E Elder · University Of Pennsylvania · R01 · FY2009 · CA
Role of MFG-E8 in Tumor Biology and Immunophysiology
$637,771Mark Udey · Division Of Basic Sciences - Nci · ZIA · FY2009 · CA
Phase III Trial of Selenium for Prostate Cancer Prevention
$637,649University Of Arizona · R01 · FY2005 · CA
Role of AMPK in melanoma brain metastasis
$637,432Bin Zheng · Cedars-Sinai Medical Center · R01 · FY2024 · CA
Mechanisms of Durable Antitumor Immunity Mediated by PI3K-targeted T cells
$637,418Chrystal Mary Paulos · Emory University · R01 · FY2023 · CA
Engineering high performing microfluidic system for rapid non-invasive isolation and expansion of circulating tumor-reactive lymphocytes
$637,371Shana O Kelley · Northwestern University At Chicago · R01 · FY2025 · CA
Ultrasmall particle-based solutions for inducing ferroptosis and improving anti-tumor immune responses in cancer
$637,054Michelle S Bradbury · Sloan-Kettering Inst Can Research · R01 · FY2021 · CA
Molecular mechanisms of allele-specific NRAS signaling and tumorigenesis
$636,917Christin E Burd · Ohio State University · R01 · FY2025 · CA
Enhancing cell therapy for brain tumors
$636,818Catherine Mary Bollard · Children'S Research Institute · U01 · FY2022 · CA
Enhancing cell therapy for brain tumors
$636,807Catherine Mary Bollard · Children'S Research Institute · U01 · FY2020 · CA
Enhancing cell therapy for brain tumors
$636,799Catherine Mary Bollard · Children'S Research Institute · U01 · FY2019 · CA
Confocal video-mosaicking microscopy to guide surgery of superficially spreading skin cancers
$636,767Milind Rajadhyaksha · Sloan-Kettering Inst Can Research · R01 · FY2023 · CA
ICON TARGETING OF TUMOR VASCULATURE AND TUMOR CELLS
$636,541Albert B Deisseroth · University Of California, San Diego · P01 · FY2009 · CA
Mechanisms of Cross-talk Between EphrinB and Alternate Signaling Pathways
$636,508Ira Daar · Division Of Basic Sciences - Nci · ZIA · FY2012 · CA
Signaling Mechanisms of EphrinB1 in Cell Adhesion, Migration and Invasion
$636,508Ira Daar · Division Of Basic Sciences - Nci · ZIA · FY2012 · CA
Enhancing cell therapy for brain tumors
$636,455Catherine Mary Bollard · Children'S Research Institute · U01 · FY2021 · CA
Validating and Characterizing a New Melanoma Therapeutic Target
$636,343Sara A Courtneidge · Oregon Health & Science University · R01 · FY2020 · CA
Defining mechanisms of how immune checkpoint inhibitor-associated bacteria modulate tumor immunity in cancer
$636,222Marlies Meisel · University Of Pittsburgh At Pittsburgh · R01 · FY2025 · CA
Control Of G Protein Signaling: Role Of The RGSs
$636,203John H Kehrl · National Institute Of Allergy And Infectious Diseases · ZIA · FY2012 · AI